Imatinib Actavis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imatinib Actavis, covering 2022-07-05 to 2022-07-05. Get the full timeline:
Most recent: EMA Withdrawn: Imatinib Actavis (imatinib) — Actavis Group PTC ehf